Xiaobo Du

17PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsNew Zealand literature (excl. Māori literature)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 19, 2026
A Theranostic Study of 177Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.

|Jan 22, 2026
Preclinical Study of CDH3-Targeted 89Zr/177Lu Theranostics in Triple-Negative Breast Cancer.

Mingming Tang, Huayan Zhang, Huan Du

|Oct 21, 2025
Ursodeoxycholic acid for the prevention of severe radiation dermatitis: a single-arm phase I/II trial protocol in patients with breast cancer undergoing postoperative radiotherapy in China.

Xinlan Liu, Binwei Lin, Yixue Wen

|Sep 05, 2025
Pain and Its Treatment Among Outpatients with Malignant Tumors in China.

Peiyang Mao, Xin Tian, Yinxia Zhan

|Aug 27, 2025
Risk prediction models for depression in cancer survivors: A systematic review and meta-analysis.

Haonan Xu, Wenqiang Tang, Yuwen Liang

|Aug 13, 2025
Impact of COVID-19 hospitalization on December 2022 hospital staff in Sichuan, China.

Jing Pu, Mi Fan, Binwei Lin

Pageof 3

Frequent Collaborators

1 joint publications

Yao Liao

1 joint publications

Peiyang Mao

1 joint publications

Hongfan Yu

1 joint publications

Qiuling Shi